全球智库信息集成服务系统(G2TT): Bargaining and International Reference Pricing in the Pharmaceutical Industry

G2TT

来源类型	Working Paper
规范类型	报告
DOI	10.3386/w30053
来源ID	Working Paper 30053
	Bargaining and International Reference Pricing in the Pharmaceutical Industry
	Pierre Dubois; Ashvin Gandhi; Shoshana Vasserman
发表日期	2022-05-16
出版年	2022
语种	英语
摘要	The United States spends twice as much per person on pharmaceuticals as European countries, in large part because prices are much higher in the US. This fact has led policymakers to consider legislation for price controls. This paper assesses the effects of a US international reference pricing policy that would cap prices in US markets by those offered in reference countries. We estimate a structural model of demand and supply for pharmaceuticals in the US and reference countries like Canada where prices are set through a negotiation process between pharmaceutical companies and the government. We then simulate the counterfactual equilibrium under such international reference pricing rules, allowing firms to internalize the cross-country externalities introduced by these policies. We find that in general, these policies would result in much smaller price decreases in the US than price increases in reference countries. The magnitude of these effects depends on the number, size and market structure of references countries. We compare these policies with a direct bargaining on prices in the US.
主题	Econometrics ; Estimation Methods ; Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Firm Behavior
URL	https://www.nber.org/papers/w30053
来源智库	National Bureau of Economic Research (United States)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/587727
推荐引用方式 GB/T 7714	Pierre Dubois,Ashvin Gandhi,Shoshana Vasserman. Bargaining and International Reference Pricing in the Pharmaceutical Industry. 2022.

条目包含的文件
文件名称/大小	资源类型	版本类型	开放类型	使用许可
w30053.pdf（1123KB）	智库出版物		限制开放	CC BY-NC-SA	浏览